North America Allergy Immunotherapies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)), Allergy type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Geography
Market Introduction
Allergen immunotherapy, also known as hypo-sensitization or desensitization, is a medical treatment for allergies. Measured doses of allergens are given to the patient resulting in reduced inflammation, which causes immune system to become less sensitive to the substance by blocking antibody function. Allergy immunotherapy primary therapeutic goals include reducing symptoms, reducing symptomatic medication use, and improving allergy-related quality of life.
Get more information on this report :
Market Overview and Dynamics
The North America allergy immunotherapies market was valued at US$ 697.53 million in 2019 and is projected to reach US$ 1,634.17 million by 2027; it is expected to grow at a CAGR of 11.3 % during the forecast period. This can be attributed to the growing developments in the healthcare sector due to R&D activities in this industry. The increasing initiatives taken by various research institutes and organizations for improving medical facilities and services are further leading to market growth. The growing number of health disorders and rising demand for improved treatment and preventive measures has led to technological advancements in the medical industry.
Key Market Segments
Based on Treatment, the SCIT segment held a larger share of the North America allergy immunotherapies market in 2019. However, the SLIT segment is expected to grow at a higher CAGR during the forecast period. Based on allergy type, the allergic rhinitis segment held the greatest share of the market in 2019, and is anticipated to register the highest CAGR in the market during forecast period.
Based on distribution channel, the hospital pharmacy settings segment held the largest share of the North America allergy immunotherapies market in 2019, and is expected to grow at the fastest CAGR during the forecast period.
Major Sources and Companies Listed
Some of the major primary and secondary sources for the North America allergy immunotherapies market included in the report are American Academy of Allergy, Asthma & Immunology, Celsion Corporation, the US Food and Drug Administration (FDA) and World Allergy Organization (WAO).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of the North America allergy immunotherapy market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different allergy immunotherapy segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the allergy immunotherapy market, providing a clear picture of future opportunities that will help Analyse, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America immunotherapy market.
NORTH AMERICA ALLERGY IMMUNOTHERAPIES MARKET SEGMENTATION
North America Allergy Immunotherapies Market – By Treatment
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
North America Allergy Immunotherapies Market – By Allergy Type
- Allergic Rhinitis
- Asthma
- Food Allergy
- Venom Allergy
- Others
North America Allergy Immunotherapies Market – By Distribution Channel
North America Allergy Immunotherapies Market – By Geography
- United Sates
- Mexico
- Canada
Company Profiles
- Johnson and Johnson Services, Inc.
- ALK Abello A/S
- Aimmune Therapeutics
- Anergis
- Circassia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Allergy Immunotherapies Market – By Treatment
1.3.2 North America Allergy Immunotherapies Market – By Allergy Type
1.3.3 North America Allergy Immunotherapies Market – By Distribution Channel
1.3.4 North America Allergy Immunotherapies Market – By Geography
2. North America Allergy Immunotherapies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Allergy Immunotherapies Market – Market Landscape
4.1 Overview
4.2 North America - PEST Analysis
4.3 Expert Opinion
5. North America Allergy immunotherapies Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Prevalence of Allergic Disorders
5.1.2 Technological Advancements in Sublingual Dosage Formulations
5.2 Key Market Restraint
5.2.1 Drawbacks Associated with the Use of Allergy Immunotherapy
5.2.2 Regulatory Variations Across Regions
5.3 Key Market Opportunities
5.3.1 Presence of Strong Product Pipeline
5.4 Future Trends
5.4.1 Increasing FDA Approvals for Drugs
5.5 Impact Analysis
6. Allergy Immunotherapies Market – North America Analysis
6.1.1 North America: Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)
7. North America Allergy Immunotherapies Market Analysis– by Treatment
7.1 Overview
7.2 North America Allergy Immunotherapies Market Share, By Treatment, 2019 & 2027 (%)
7.3 Subcutaneous Immunotherapy (SCIT)
7.3.1 Overview
7.3.2 North America Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
7.4 Sublingual Immunotherapy (SLIT)
7.4.1 Overview
7.4.2 North America Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
8. North America Allergy Immunotherapies Market Analysis– by Allergy Type
8.1 Overview
8.2 North America Allergy Immunotherapies Market Share, By Allergy Type, 2019 & 2027 (%)
8.3 Allergic Rhinitis
8.3.1 Overview
8.3.2 Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
8.4 Asthma
8.4.1 Overview
8.4.2 Asthma Market Revenue and Forecasts to 2027 (US$ Million)
8.5 Food Allergy
8.5.1 Overview
8.5.2 Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.6 Venom Allergy
8.6.1 Overview
8.6.2 Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.7 Other Allergies
8.7.1 Overview
8.7.2 Others Market Revenue and Forecasts to 2027 (US$ Million)
9. North America Allergy Immunotherapies Market Analysis– by Distribution Channel
9.1 Overview
9.2 North America Allergy Immunotherapies Market Share, By Distribution Channel, 2019 & 2027 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 North America Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 North America Retail PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 North America Online PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)
10. Allergy Immunotherapies – Geographic Analysis
10.1.1 Overview
10.1.2 orth America: Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)
10.1.3 North America: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Allergy immunotherapies market, by Country, 2019 & 2027 (%)
10.1.7 US: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on North America Allergy Immunotherapies Market
12. Company Profiles
12.1 ALK-Abelló A/S
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 AIMMUNE THERAPEUTICS, INC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Johnson and Johnson Services, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
13. Appendix
13.1 Glossary of Terms
LIST OF TABLES
Table 1. North America Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 4. US Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 5. US Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 6. US Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Glossary of Terms, Allergy Immunotherapies Market
LIST OF FIGURES
Figure 1. North America Allergy Immunotherapies Market Segmentation
Figure 2. North America Allergy Immunotherapies Market Overview
Figure 3. Subcutaneous Immunotherapy (SCIT) Segment Held Largest Share of Allergy immunotherapies market
Figure 4. United States Is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Allergy Immunotherapies Market- Leading Country Markets (US$ Million)
Figure 6. North America PEST Analysis
Figure 7. Allergy immunotherapies Market Impact Analysis of Driver and Restraints
Figure 8. North America Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)
Figure 9. North America Allergy Immunotherapies Market Share, by Treatment, 2019 & 2027 (%)
Figure 10. North America Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
Figure 11. North America Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
Figure 12. North America Allergy Immunotherapies Market Share, by Allergy Type, 2019 & 2027 (%)
Figure 13. Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
Figure 14. Asthma Market Revenue and Forecasts to 2027 (US$ Million)
Figure 15. Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 16. Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 17. Others Market Revenue and Forecasts to 2027 (US$ Million)
Figure 18. North America Allergy Immunotherapies Market Share, by Distribution Channel, 2019 & 2027 (%)
Figure 19. North America Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 20. North America Retail PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)
Figure 21. North America Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 22. North America: Allergy Immunotherapies Market, by Key Country – Revenue (2019) (USD Million)
Figure 23. North America Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)
Figure 24. North America: Allergy immunotherapies market, by Country, 2019 & 2027 (%)
Figure 25. US: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Canada: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Mexico: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Impact of COVID-19 Pandemic on allergy immunotherapies market in North American Countries
- Johnson and Johnson Services, Inc.
- ALK Abello A/S
- Aimmune Therapeutics
- Anergis
- Circassia
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America allergy immunotherapy market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America allergy immunotherapy market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.